{"SPADE_UN_13444": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13444", "Peptide Name": "CPF-2-2 (Variant of CPF-C1)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "N/A", "Sequence": "KFWSLLKKALRLWAKVL", "Sequence Length": 17, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+"], "Target Organism": "[Ref.32590058] Gram-positive:S. aureus ATCC 25923 (MIC = 8 μg/mL, MIC = 128 μg/mL in 10% serum, MIC = 8 μg/mL in 150 mM, MBIC50 = 16 μg/mL, MBIC90 = 16 μg/mL, MBEC = 16 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 16 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 16 μg/mL), S. aureus 794 (MIC = 8 μg/mL)", "Hemolytic Activity": "[Ref.32590058]It showed almost no hemolytic activity, even at concentrations up to 128 μg/ml", "Cytotoxicity": "Not found", "Binding Target": "Bacterial membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "Mixed (D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13 and D-Lys15)", "Structure Description": "Not found", "Formula": "C105H170N26O19", "Mass": 2100.64, "PI": 11.33, "Net Charge": 5, "Hydrophobicity": 0.41, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Comments": "CPF-2 has potential as a lead compound to treat infections caused by S. aureus and MRSA, including the associated biofilms.", "Literature": [{"Title": "CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA", "Pubmed ID": "32590058", "Reference": "Biochimie. 2020 Sep;1761-11. doi 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.", "Author": "Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32590058"}], "Frequent Amino Acids": "LKA", "Absent Amino Acids": "CDEGHIMNOPQTUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 9, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11735", "Similarity": 0.9411764705882353, "Sequence": "KFWSLLKKALRLWANVL"}, {"SPADE_ID": "SPADE_UN_11736", "Similarity": 0.9411764705882353, "Sequence": "KFWSLLKKALRLWANVL"}, {"SPADE_ID": "SPADE_UN_11737", "Similarity": 0.9411764705882353, "Sequence": "KFWKLLKKALRLWAKVL"}]}}}